Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides

Biochemical and Biophysical Research Communications

Volumn 415, Issue 4, 2011, Pages 563-566

  Wolter, Sabine ^a   Golombek, Marina ^a   Seifert, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CCMP; CUMP; PKA; PKG; Second messenger

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ISOENZYME; PHOSPHODIESTERASE; PURINE NUCLEOTIDE; PYRIMIDINE NUCLEOTIDE;

ARTICLE; ENZYME ACTIVATION; ENZYME SPECIFICITY; HYDROLYSIS; PRIORITY JOURNAL; SECOND MESSENGER; SMOOTH MUSCLE RELAXATION;

CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIIALPHA SUBUNIT; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; NUCLEOTIDES, CYCLIC; URIDINE MONOPHOSPHATE;

EID: 84855880193     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.093     Document Type: Article

References (24)

1. Taylor S.S., Yang J., Wu J., Haste N.M., Radzio-Andzelm E., Anand G. PKA: a portrait of protein kinase dynamics. Biochim. Biophys. Acta 2004, 697:259-269.
2. Kopperud R., Krakstad C., Selheim F., Doskeland S.O. cAMP effector mechanisms. Novel twists for 'old' signalling system. FEBS Lett. 2003, 546:121-126.
3. Francis S.H., Corbin J.D. Cyclic nucleotide-dependent protein kianses: Intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci. 1999, 36:275-328.
4. Broillet M.C., Firestein S. Cyclic nucleotide-gated channels. Molecular mechanisms of activation. Ann. NY Acad. Sci. 1999, 868:730-740.
5. Francis S.H., Busch J.L., Corbin J.D., Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacological. Rev. 2010, 62:525-563.
6. Herberg F.W., Taylor S.S., Dostmann W.R. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase. Biochemistry 1996, 35:2934-2942.
7. Hofmann F. The biology of cyclic GMP-dependent protein kinase. J. Biol. Chem. 2005, 280:1-4.
8. Faux M.C., Scott J.D. Molecular glue: kinase anchoring and scaffold proteins. Cell 1996, 85:9-12.
9. Kim C., Cheng C.Y., Saldanha S.A., Taylor S.S. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 2007, 130:1032-1043.
10. Desch M., Schinner E., Kees F., Hofmann F., Seifert R., Schlossmann J. Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I. FEBS Lett. 2010, 584:3979-3984.
11. Roskoski R. Assays of protein kinase. Methods Enzymol. 1983, 99:3-6.
12. Smith S.B., White H.D., Siegel J.B., Krebs E.G. Cyclic AMP-dependent protein kinase I: cyclic nucleotide binding structural changes and release of the catalytic subunits. Proc. Natl. Acad. Sci. 1981, 78:1591-1595.
13. Rannels S.R., Cobb C.E., Landiss L.R., Corbin J.D. The regulatory subunit monomer of cAMP-dependent protein kinase retains the salient kinetic properties of the native dimeric subunit. J. Biol. Chem. 1985, 260:3423-3430.
14. Reinecke D., Burhenne H., Sandner P., Kaever V., Seifert R. Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated. FEBS Lett. 2011, 585:3259-3262.
15. Kenakin T. Functional selectivity and biased receptor signalling. J. Pharmacol. Exp. Ther. 2011, 336:296-302.
16. 1-adrenergic receptor. Nature 2011, 469:241-244.
17. Burhenne H., Beste K.Y., Spangler C.M., Voigt U., Kaever V., Seifert R. Determination of cytidine 3',5'-cyclic monophosphate and uridine 3',5'-cyclic monophosphate in mammalian cell systems and in human urine by high-performance liquid chromatography/mass spectrometry. Naunyn-Schmiedeberg's Arch. Pharmacol. 2011, 383(Suppl. 1):P096.
18. Cech S.Y., Ignarro L.J. Cytidine 3',5'-monophosphate (cyclic CMP) formation in mammalian tissue. Science 1977, 198:1063-1065.
19. Gaion R.M., Krishna G. Cytidylate cyclase: the product isolated by the method of Cech and Ignarro is not cytidine 3',5'-monophosphate. Biochem. Biophys. Res. Commun. 1979, 86:105-111.
20. Yamamoto I., Takai T., Mori S. Cytidylate cyclase activity in mouse tissues: the enzymatic conversion of cytidine 5'-triphosphate to cytidine 3',5'-cyclic monophosphate. Biochim. Biophys. Acta 1989, 993:191-198.
21. Newton R.P., Salvage B.J., Hakeem N.A. Cytidylate cyclase: development of assay and determination of kinetic properties of a cytidine 3',5'-cyclic monophosphate-synthesizing enzyme. Biochem. J. 1990, 265:581-586.
22. Beste K.Y., Stasch J.-P., Kaever V., Seifert R. Divalent cation-dependent substrate specificity of recombinant soluble guanylyl cyclase. Naunyn-Schmiedeberg's Arch. Pharmacol. 2011, 383(Suppl. 1):P024.
23. R. Seifert, G.H. Lushington, T.-C. Mou, A. Gille, S.R. Sprang, Inhibitors of membranous adenylyl cyclases, Trends Pharmacol. Sci. 23, in press.
24. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.